Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

4D Molecular Therapeutics Q2 EPS $(0.87) Down From $(0.28) YoY

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.87) per share. This is a 210.71 percent decrease over losses of $(0.28) per share from the same period last year.
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.87) per share. This is a 210.71 percent decrease over losses of $(0.28) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Stitch Fix Faces Price Target Cuts By Analysts Following Q4 Results, Shares Slide

By Lisa Levin
September 21, 8:59 AM
Stitch Fix, Inc. (NASDAQ: SFIX) reported a wider-than-expected loss for its fourth quarter and issued weak Q1 sales guidance. Stitch Fix said it expects fiscal first-quarter revenue to be between $455 million and $465 million versus the estimate of $522.68 million.

SFIX